MoneyWorks4Me

Dipna Pharmachem informs about disclosure

18 Apr 2024 Evaluate
Dipna Pharmachem has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Shah.

The above information is a part of company’s filings submitted to BSE.

Peers